Contineum Therapeutics, Inc.
Historical 13F Holders
Symbol
CTNM
CUSIP
21217B100
All holders as of
Q1 2025
Type
Equity
Class
CL A
Reported Value, Excluding Options
Total Filings
Period
Filings
Shares, Excl. Options
Value, Excl. Options
Options Value
2025 Q1
63
15.1 M
$106 M
$0
2024 Q4
63
15.8 M
$231 M
$0
2024 Q3
53
13.6 M
$256 M
$0
2024 Q2
52
13.0 M
$229 M
$0